Charles Schwab Investment Management Inc Cyma Bay Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

$429 Billion
Q1 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	BUY	$12.63 - $24.47 $693,639 - $1.34 Million	54,920 Added 6.88%	853,475 $20.2 Million
Q3 2023 Nov 08, 2023	BUY	$10.86 - $17.62 $5.8 Million - $9.41 Million	533,821 Added 201.64%	798,555 $11.9 Million
Q2 2023 Aug 09, 2023	BUY	$7.47 - $10.95 $1.69 Million - $2.48 Million	226,254 Added 587.98%	264,734 $2.9 Million
Q1 2023 May 11, 2023	BUY	$5.88 - $9.59 $23,014 - $37,535	3,914 Added 11.32%	38,480 $335,000
Q3 2022 Nov 14, 2022	SELL	$2.77 - $4.25 $38,907 - $59,695	-14,046 Reduced 28.89%	34,566 $121,000

Q2 2022 Aug 15, 2022	SELL	$1.72 - $3.39 $327,837 - $646,144	-190,603 Reduced 79.68%	48,612 $144,000
Q1 2022 May 13, 2022	BUY	$2.77 - $3.64 $164,139 - $215,691	59,256 Added 32.93%	239,215 $744,000
Q4 2021 Feb 11, 2022	BUY	$3.23 - $4.6 $19,380 - $27,599	6,000 Added 3.45%	179,959 $609,000
Q3 2021 Nov 16, 2021	SELL	$3.47 - $4.42 $1.24 Million - $1.58 Million	-357,375 Reduced 67.26%	173,959 $635,000
Q2 2021 Aug 16, 2021	SELL	$3.94 - $4.92 $30,653 - $38,277	-7,780 Reduced 1.44%	531,334 $2.32 Million
Q1 2021 May 17, 2021	BUY	$4.23 - $6.55 $82,150 - $127,207	19,421 Added 3.74%	539,114 $2.45 Million
Q4 2020 Feb 16, 2021	SELL	$5.73 - $9.03 $4,154 - $6,546	-725 Reduced 0.14%	519,693 $2.98 Million
Q3 2020 Nov 13, 2020	BUY	$3.32 - $7.24 $280,500 - $611,693	84,488 Added 19.38%	520,418 $3.77 Million
Q2 2020 Aug 14, 2020	BUY	$1.41 - $4.25 $85,537 - $257,826	60,665 Added 16.17%	435,930 $1.52 Million
Q1 2020 May 15, 2020	BUY	$1.25 - $2.02 $6,951 - $11,233	5,561 Added 1.5%	375,265 $556,000
Q4 2019 Feb 07, 2020	SELL	$1.33 - $5.93 $28,454 - $126,866	-21,394 Reduced 5.47%	369,704 $725,000
Q3 2019 Nov 08, 2019	SELL	$5.12 - $7.21 $10,368 - $14,600	-2,025 Reduced 0.52%	391,098 $2 Million
Q2 2019 Aug 09, 2019	BUY	$6.05 - $13.66 $170,640 - $385,280	28,205 Added 7.73%	393,123 $2.82 Million
Q1 2019 May 14, 2019	BUY	$8.16 - $13.42 $337,163 - $554,500	41,319 Added 12.77%	364,918 $4.85 Million
Q4 2018 Feb 14, 2019	SELL	$6.54 - $11.74 $13,420 - $24,090	-2,052 Reduced 0.63%	323,599 $2.55 Million
Q3 2018 Nov 13, 2018	BUY	$10.88 - $14.52 $2.13 Million - $2.84 Million	195,486 Added 150.18%	325,651 $3.61 Million
Q2 2018 Aug 08, 2018	BUY	$10.66 - $14.38 $1.17 Million - $1.58 Million	109,800 Added 539.16%	130,165 $1.75 Million
Q1 2018 May 07, 2018	BUY	$9.0 - $15.16 $71,100 - $119,764	7,900 Added 63.38%	20,365 $265,000
Q4 2017 Jan 17, 2018	BUY	$7.67 - $9.31 $95,606 - $116,049	12,465	12,465 $115,000

Others Institutions Holding CBAY

# of Institutions

Shares Held

1.88M

Call Options Held

Put Options Held

View Full List

About CymaBay Therapeutics, Inc.

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

More about CBAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account